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ABSTRACT  We have examined the effects of various mannans, glycoproteins, oligosaccharides, 
monosaccharides,  and sugar phosphates on  the binding and  phagocytosis of yeast cell  walls 
(zymosan)  by  mouse  peritoneal  macrophages.  A  phosphonomannan  (PO4:mannose  ratio  = 
1:8.6) from  K!oeckera  brevis  was  the  most  potent  inhibitor tested;  it inhibited  binding  and 
phagocytosis by 50% at concentrations of ~3-5/~g/ml  and  10 p,g/ml,  respectively. Removal of 
the  phosphate  from  this  mannan  by  mild  acid  and  alkaline  phosphatase  treatment  did  not 
appreciably reduce  its capacity to inhibit zymosan  phagocytosis.  The mannan  from  Saccharo- 
myces  cerevisiae  mutant  LB301 inhibits  phagocytosis  by  50%  at  0.3  mg/ml,  and  a  neutral 
exocetlutar glucomannan  from  Pichia pinus inhibited  phagocytosis by 50% at  1 mg/ml.  Cell 
wall  mannans  from  wild  type  S.  cerevisiae X2180, its  mnn2 mutant which contains  mannan 
with predominantly 1 ---* 6-1inked  mannose  residues, yeast exocellular mannans  and  O-phos- 
phonomannans were less efficient inhibitors requiring concentrations of t-5 mg/ml  to achieve 
50%  reduction  in  phagocytosis.  Horseradish  peroxidase,  which  contains  high-mannose  type 
oligosaccharides,  was also inhibitory. 
Mannan  is  a  specific  inhibitor  of  zymosan  binding  and  phagocytosis.  The  binding  and 
ingestion of zymosan  but not of IgG- or complement-coated  erythrocytes can  be obliterated 
by  plating  macrophages  on  substrates  coated  with  poly-L-lysine  (PLL)-mannan.  Zymosan 
uptake was completely  abolished  by trypsin treatment  of  the  macrophages  and  reduced  by 
50-60% in the presence of 10 mM  EGTA. Pretreatment of the macrophages  with chloroquine 
inhibited zymosan  binding and  ingestion. These results support the proposal  that the macro- 
phage  mannose/N-acetylglucosamine  receptor  (P. Stahl, J. S. Rodman,  M. J. Miller, and  P. H. 
Schlesinger,  1978, Proc.  Natl.  Acad.  Sci.  U.  S.  A.  75:1399-1403,  mediates  the  phagocytosis of 
zymosan  particles. 
The phagocytosis of zymosan (yeast cell walls) has been clas- 
sified,  together with  the  ingestion  of particles  such  as  latex, 
starch, and particles with denatured surfaces, as "nonspecific" 
phagocytosis, to distinguish it from receptor-mediated phago- 
cytosis of particles coated with known ligands such as immu- 
noglobulin G  (IgG) or complement (22).  Yeast cell wails are 
composed predominantly of glucose- or mannose-containing 
polysaccharides.  The  discovery of cell  surface  receptors  that 
mediate the pinocytosis of mannose- or mannose phosphate- 
containing oligosaccharides (9, 13, 15, 25) raised the possibility 
that zymosan uptake  might be mediated  by one or more of 
these receptors. Exploring this question, Warr (32) showed that 
the binding of  intact yeast particles to rat alveolar macrophages, 
ceils  that  are especially rich in mannose receptors,  could be 
blocked by mannose and by proteins containing "high man- 
nose" type oligosaccharides. The experiments described in the 
present  report extend and amplify Warr's findings in several 
160 
ways. We show that mannan from Kl.  brevis is an especially 
potent and specific inhibitor of the binding and ingestion of 
Saccharomyces cerevisiae and Kloeckera brevis zymosans, and 
that this inhibitory activity is unaffected by mild acid hydrol- 
ysis and phosphatase treatment  of KI.  brevis  mannan.  More- 
over, we show that macrophages plated on substrates  coated 
with mannose-containing oligosaccharides or incubated in me- 
dium containing chloroquine are specifically depleted in their 
capacity  to  bind  and  ingest  zymosan,  In  sum,  our  results 
indicate  that  zymosan  ingestion  is  receptor-mediated;  they 
suggest  that  this  uptake  is  mediated  by  the  Man/GlcNAc 
receptor described by Stahl et al. (25). 
MATERIALS  AND  METHODS 
NCS mice and sheep erythrocytes were obtained from the Rockefeller University 
animal facility. Brewer thioglycollate medium and proteose peptone were from 
Difco Laboratories, (Detroit, MI); anti-sheep erythrocyte IgG was from Cordis 
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Sigma Chemical Co. (St. Louis, MO) or Dr. Clinton Ballou of the University of 
California, Berkeley. Mannans from mutants of S. cerevisiae X2180, mnn2 (2l) 
and LB-301 (2), as well as phosphomannan 8.6 from KI brevis (28) were generous 
gifts of Dr. Clinton Ballou. Mannans were dialysed overnight against 1 N  acetic 
acid and lyophilized before use. The structures of some of these mannans are 
shown in Fig. 1. KI. brevis strain 55~15 was a generous gift of Dr. Herman Phaff 
of the University of California, Davis; KI. brevis zymosan particles were prepared 
by autoclaving a  25% (vol/vol) log phase KL  brevis suspension in  Dulbecco's 
phosphate-buffered saline without Ca  ++ and Mg  ÷÷ (PD), followed by reduction 
with mercaptoethanol and alkylation with iodoacetamide as described (17). S. 
cerevisiae  zymosan was purchased from Sigma Chemical Co.  and washed as 
described (18). Yeast exocellular mannans (23, 24) were generous gifts of Dr. M. 
Slodki of the Northern Research Laboratory; poly-L-lysine  (PLL) (mol wt 90,000) 
was  obtained  from  Miles  Laboratories  Inc.  (Elkhart,  IN);  Gold  Seal  glass 
coverslips from Becton, Dickinson & Co. (Oxnard, CA); Escherichia coil alkaline 
phosphatase and 3X crystallized trypsin from Worthington Biochemical Corp. 
(Freehold, N J); horseradish peroxidase type II, mannose-6-phosphate, a-methyl- 
D-mannopyranoside grade III,  l-ethyl-3-(3-dimethylaminopropyl)  carbodiimide 
hydrochloride and bovine serum albumin (BSA) from Sigma Chemical Co.; D- 
mannose from Pfanstiehl Laboratories, Inc. (Waukegan, IL).  [~2sI]-Nal  (carrier 
free) was purchased from Amersham Corp. (Arlington Heights, IL) and iodogen 
from Pierce Chemical Co. (Rockford, IL).  All other chemicals were obtained 
from commercial sources and were of the purest grade available. Fetal bovine 
serum (FBS) (Flow Laboratories, Inc., Rockville, MD) was heated at 56°C for 30 
min before use. 
Mannose oligosaccharides were obtained from the acetolysis of S.  cerevisiae 
mannan (Sigma Chemical Co.)  by the  method of Kocourek and Ballou (16) 
followed by chromatography on a  column (2.5 x  100 cm) of P-2 (-400 mesh, 
Bio-Rad Laboratories, Richmond, CA) eluted with water at 48°C. The carbo- 
hydrate peaks were pooled, lyophilized, and analyzed by thin-layer chromatog- 
raphy on silica gel G plates developed with butanol/acetic acid/water (100:50:50) 
using stachyose, raffinose, melibiose, and manrtose as standards (14). The indi- 
vidual oligosaccharides visualized by a-naphthol-sulphuric acid (14) were essen- 
tially homogeneous and migrated with Re values similar to the corresponding 
standards with the same degree of polymerization. The oligosaccharides did not 
contain any phosphate as determined by the method of Bartlett (3). 
Cell Cultures:  Mouse peritoneal macrophages were harvested by the 
method of Cohn and Benson (5) and plated on coverslips (13 mm diameter) in 
35-mm dishes  essentially  as  described  (18).  Resident  and  proteose  peptone- 
elicited (7) macrophages were plated at a density of 2 x  10  ~ peritoneal cells per 
coverslip. Thioglycollate-elicited macrophages were plated at a density of I x  106 
ceils  per  35-mm dish  (18).  Macrophage cultures were  incubated at  37°C  for 
16-24 h; before use, the coverslip cultures were washed as described below. For 
experiments employing PLL-, PLL-mannan-, and PLL-bovine serum albumin 
(PLL-BSA)-coated substrates, cells were plated on appropriately coated  13-ram 
coverslips (see below) in  16-mm Costar wells at 3  x  10  '~ cells per well (19) in 
Eagle's minimal essential medium (MEM) with 10% FBS, incubated at 37°C for 
4  h, and washed to remove nonadherent cells. Despite vigorous washing, many 
lymphocytes remained  adherent  to  these  PLL-,  PLL-mannan- or PLL-BSA- 
coated coverslips. For this reason these cultures were further incubated at 37°C 
in MEM- 10% FBS overnight. After this period the lympbocytes  detached, leaving 
a  population of viable, well-spread cells >95% of which are macrophages. For 
experiments using macrophages on untreated coverslips, cells were plated at the 
densities described above in MEM-10% FBS for 4 h at 37°C, washed twice with 
MEM, and incubated in MEM-10% FBS overnight. 
Binding  and  Phagocytosis  Assays:  Prior to use, coverslip cultures 
were washed by dipping in cold MEM and placed in  16-mm Costar wells with 
0.5 ml of medium containing MEM and 25 mM N-2-hydroxyethylpiperazine-N'- 
2-ethanesulfonic acid (HEPES) (pH 7A) with or without inhibitors as appropriate 
and preincubated for 15 min at 4°C for binding assays or at 37°C for phagocytosis 
assays. For binding, 20 ~tl of a 5% (vol/vol) suspension of particles was added per 
well and attachment was allowed to proceed for 60-90 min at 4°C. For phago- 
cytosis, 20/~1 of a 2% (vol/vol) suspension of particles was added to each well for 
30  min  at  37°C.  Phagocytosis of IgG-coated  erythrocytes was  measured  as 
described (18). At the end of the experiment the cultures were washed with PD 
and fixed in 2.5% glutaraldehyde in PD. Ingestion and binding were scored with 
a  phase-contrast microscope by counting the  number  of particles bound  or 
ingested by  100 macrophages. Under phase-contrast optics, ingested zymosan 
particles can be readily distinguished from bound particles by the location of the 
whole  particle  within  the  periphery of the  macrophage, by  the  loss  of the 
characteristic grayish color of uningested particles, and by the  presence of a 
vacuole around the particle. The  binding of complement-coated erythrocytes, 
prepared  as  described  (4),  was  performed  by  adding  20 /d  of 5%  (vol/vol) 
complement-coated erythrocytes to resident macrophages on coverslips in 500 
#i  of MEM-25  mM  HEPES,  pH 7.4-2% FBS. The cultures were incubated at 
37°C for 30 min, washed in PD, and fixed in 2.5% glutaraldehyde in PD. The 
phagocytic or binding index is defined as the number of particles ingested or 
bound by 100 macrophages. 
Preparation  of  Coverslips  Coated  with  Poly-t-lysine, 
Poly~t-lysine-bovine  Serum Albumin and Poly-L-lysine-man- 
nan:  Poly-L-lysine-coated coverslips were prepared by the method of Michl 
et al. (19). Mannan from S. cerevisiae  was clarified by centrifugation of a  100 mg 
per ml aqueous solution at 23,000 g  for 20 min; the mannan in the supernatant 
was reprecipitated with Fehling's solution, washed in methanol/acetic acid (5/1), 
dialyzed  against  1  N  acetic  acid,  and lyophilized (16).  100 ~1  of a  solution 
containing 50 mg/ml BSA or mannan and 10 mg/ml of l-ethyl-3-(3-dimethylam- 
inopropyl) carbodiimide hydrochloride were layered over PLL-coated coverslips 
and incubated at 4°C overnight. The amount of mannan or BSA coupled was 
quantitated by adding 1 x  107 cpm of iodinated mannan (2.3 x  10  r' cpm/~tg) or 
BSA (4.4 x  10  s cpm/~g) to each ml of the coupling mixture and counting the 
coverslips for radioactivity. ~4.3  +_ 0.8/~g mannan or 9.0 +  3.0/zg BSA were 
coupled per coverslip. 
Mild Acid Hydrolysis  and Alkaline Phosphatase Treatment 
of  Mannan:  KI.  brevis  mannan (20  mg  in  1  ml  of 0.01  M  HC1)  was 
hydrolysed  for  30  min  at  100°C,  dialyzed  exhaustively  against  water,  and 
lyophilized. 8 mg of this acid-hydrolysed mannan was dissolved in 0.8 ml of 0.75 
M Tris HCI, pH 8.0 and incubated with 49 U  of E. coil alkaline phosphatase (sp 
act 31  U/mg) at 37  °  for 24 h. The reaction was terminated by incubating the 
mixture for 3 rain in a boiling water bath. The mannan was dialyzed exhaustively 
against  1  M  acetic acid and  lyophilized.  The  carbohydrate and  phosphorus 
content of each preparation was quantitated. The mannose/phosphate ratio was 
9.1 for the initial mannan, 8.2 for the acid-treated mannan, and 23.5 for the mild 
acid- and alkaline phosphatase-treated mannan. The  final product contained 
about 35% of the phosphate of the acid-treated mannan. 
General Methods:  lodination of mannan and BSA was performed as 
described (11). Phosphorus content of mannan was measured by the method of 
Bartlett (3). Carbohydrates were quantitated by the phenol-sulphuric acid method 
(6). Alkaline phosphatase activity was measured as described in the Worthington 
Enzyme manual. 
Ceils  for trypsinization were washed three  times  with  MEM,  followed by 
treatment with 1 mg/ml trypsin in MEM-25 mM HEPES, pH 7.4 at 37°C for 30 
min. The trypsin-containing  medium was aspirated and excess trypsin neutralized 
with MEM-10% FBS. Cells were washed twice again with MEM before use. 
For chloroquine inhibition assays, 8 x  104 resident macrophages were plated 
on 13-mm coverslips in MEM-10% FBS, incubated overnight, washed two times 
with MEM, and incubated in  16-ram Costar wells for 1 h  at 37°C in 500 #1 of 
MEM containing 25 mM HEPES (pH 7.4), 2% FBS to which chloroquine and 1 
or 10 mg/ml S. cerevisiae  mannan were added as indicated. The ceils were then 
washed three times with cold MEM and further incubated at 37°C in control or 
chloroquine-containing medium to which S. cerevisiae  or KI. brevis zymosan was 
added to measure phagocytosis and binding, respectively. 
RESULTS  AND  DISCUSSION 
To identify oligosaccharides that might be useful as probes of 
the macrophage zymosan uptake system we screened a number 
of mannans for  their capacity  to  inhibit phagocytosis  of S. 
cerevisiae zymosan. Significant inhibition of zymosan phago- 
cytosis was observed with mannans from KI. brevis, wild type, 
and sugar transferase mutants of S. cerevisiae, and Pichiapinus 
(Table  I).  Other  exocellular mannans  and  phosphomannan 
monoesters obtained from Hansenula capsulata,  Torulopsis pi- 
nus,  Pichia  sp.,  Hansenula  minuta,  and  Pichia  raucosa  were 
weak inhibitors (data not shown). 
To explore further the relationship between mannan struc- 
ture and inhibitory potency we studied the dose dependence of 
inhibition of zymosan uptake by mannans from wild type and 
mutant S. cerevisiae. Mannan from wild type S. cerevisiae at a 
concentration  of  1  mg/ml  inhibited  zymosan  ingestion  by 
-50% (Fig.  2).  Mannan from the S.  cerevisiae mnn2 mutant, 
which has a  1 ---, 6-1inked linear array of mannosyl residues in 
its outer chain but lacks the 1 ---> 2- and 1 ~  3-1inked mannosyl 
oligosaccharide branches found in wild type mannan (Fig.  1), 
was about twofold less effective than wild type mannan (Fig. 
2). Mannan from another S. cerevisiae mutant LB-301, derived 
from  mnn2,  has  a  truncated  outer  chain  of  1  ---*  6-1inked 
mannosyl residues. LB-301 mannan was approximately 10-fold 
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Inhibition of Resident Macrophage Phagocytosis of S. cerevisiae Zymosan by Yeast Mannans* 
NRRL no. of  Phosphate 
Source of mannan  yeast strain  Type of mannan  content 
Phagocytosis (% control) at 
mannan concentration~ 
5  3  1 
Cell wall mannans 
KI, brevis 55-45  --  O-phosphonomannan 
5. cerevisiae X2180  --  O-phosphonomannan 
Exocellular mannans 
P. pinus  Y-2579 
H. holstii  Y-2448 
Sp, sp.ll  Y-6493 
#mol/mg  mg/ml 
rnannan 
0.59  2  3  5 
0.13  18  30  43 
Neutral gtucomannan  0.01  6  15  20 
O-phosphonoglucomannan  0.42  6  18  42 
Neutral mannan  0.04  46  73  ND§ 
O-phosphonomannan  0.68  27  53  ND 
O-phosphonomannan monoester  0.45  37  72  ND 
O-phosphonoglucogalactan  0.71  12  31  71 
* Overnight cultures of macrophages at 8 x  104  macrophage per 13-mm coverslip in MEM-10% FBS were washed with MEM, pretreated with 
the mannans in 0.5 ml of MEM-2% FBS-25 mM  HEPES, pH 7.4 for 15 •in  at 37°C before the addition of 20#t of 2%  S. cerevisiae  zymosan. 
The macrophages were allowed to phagocytose for 30 min at 37°C and then washed in  PD and fixed in 2.5% glutaraldehyde in  PD. The 
number of zymosan particles ingested was scored by counting the number of particles ingested by 100 macrophages with  phase-contrast 
microscopy. 
:l: The results  represent the mean of three experiments. 
§ ND, not determined. 
H  This is not a mannan, but a galactan containing exclusively glucose, galactose, and phosphate. 
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(A)  Sacchoromyces cerevisioe  (B)  Kloeckero  brevi$ 
FIGURE  1  Structure of the outer chains of (A)  S. cerevisiae X2180 
mannan  and  mannans  produced  by its  mutants  (1);  and  (B)  KL 
brevis mannan (28). 
Control 
600 
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0.01  0.1  I  I0 
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FIGURE  2  Inhibition  of  resident  macrophage  phagocytosis  of  S. 
cerevisiaezymosan by different mannans. Resident macrophages on 
13-ram  diameter glass  coverslips were  preincubated  in  0.5  ml  of 
MEM containing 2% FBS and 25 mM  HEPES, pH 7.4 in Costar wells 
with or without inhibitor mannan for 15 min at 37°C.  20/~1 of 2% S. 
cerevisiae  zymosan in  PD were then added and the cultures were 
incubated for an additional 30 rain at 37°C. The cultures were then 
washed, fixed, and assayed microscopically for zymosan ingestion. 
O,  S. cerevisiae  X2180 mannan; O, mannan from the  mnn2 mutant 
of X2180; x, mannan from the LB-301 mutant of X2180; •,  KI. brews 
mannan with a mannose/phosphate ratio of 8.6:1. 
more potent than wild type or mnn2 mannan as a phagocytosis 
inhibitor.  The  most  effective  phagocytosis  inhibitor  was  a 
mannan  fraction  with  a  mannose:phosphate  ratio  of  8.6:1 
purified  from  KI.  brevis  (28).  It  is  at  least  two  orders  of 
magnitude better, on a weight basis, than wild type S. cerevisiae 
mannan in inhibiting zymosan phagocytosis (Fig. 2). 
Inflammatory macrophages elicited with thioglycollate me- 
dium or proteose peptone broth are larger and more phagocytic 
(4) than resident macrophages. To determine whether mannan 
affects zymosan uptake by these cells we incubated them with 
S.  cerevisiae  zymosan in the presence  of varying amounts of 
KI.  brevis  or  S.  cerevisiae  mannans.  Both  types  of mannan 
inhibited zymosan ingestion by thioglycollate-elicited and pro- 
teose peptone-elicited macrophages (Fig. 3). However, the two 
types of inflammatory macrophages differed in their suscepti- 
bility to mannan inhibition of zymosan uptake. Thioglycollate- 
elicited  macrophages were inhibited  by lower concentrations 
of mannan than were resident  macrophages,  whereas the re- 
verse was observed with proteose peptone-elicited macrophages 
(Fig. 3). It is relevant, and should be noted here, that Ezekowitz 
et  al.  (8)  found  marked  variation  in  the  activity  of  Man/ 
GIcNAc  receptors  on  mouse  macrophages  depending  upon 
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FIGURE  3  Phagocytosis inhibition  of different  cell  types by yeast 
mannans.  Inhibition  of  S.  cerevisiae  zymosan  ingestion  was  per- 
formed  as in  Fig. 2. C), •  proteose peptone-elicited macrophages; 
A,  A  resident  macrophages;  F-i, •  thioglycollate-elicited  macro- 
phages.  Open symbols, C), A, I-1, inhibition  by  KL  brevis mannan; 
closed symbols @, &, •,  inhibition by S. cerevisiae X2180 mannan. 
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data  in  Fig.  3  suggest  that  the  number  and/or  affinity  of 
macrophage receptors for zymosan varies, depending upon the 
agent used to elicit the macrophages. 
Mannans Selectively  Inhibit Phagocytosis 
of Zymosan 
To  determine  whether  mannans  are  general  inhibitors  of 
macrophage phagocytosis, or whether they act selectively on a 
subset of macrophage membrane receptors, we incubated res- 
ident macrophages with IgG-coated sheep erythrocytes in the 
presence of varying concentrations of KI. brevis mannan. This 
mannan inhibited  phagocytosis of S.  cerevisiae  zymosan, but 
had no inhibitory effect on Fc receptor-mediated ingestion of 
IgG-coated erythrocytes  (Fig.  4).  This  experiment  indicates 
that mannans do not inhibit  phagocytosis per se;  it suggests 
that the mannans affect a  specific subset of receptors on the 
macrophage surface. 
Mannans Inhibit Binding of Zymosan to 
the Macrophage 
S.  cerevisiae  zymosan does  not  bind  efficiently to macro- 
phages  at  4°C  (<250  particles  bound  per  100  resident  or 
proteose  peptone-elicited  macrophages).  Because  KI.  brevis 
mannan is a  much more potent inhibitor of zymosan uptake 
than S. cerevisiae mannan, we reasoned that cell walls prepared 
from Kl.  brevis  might have  a  higher  affinity for the  macro- 
phages  than  S.  cerevisiae  zymosan.  Indeed,  when  KI.  brevis 
zymosan was  incubated  with  macrophages  at  4°C,  the  KI. 
brevis  zymosan  was  bound  efficiently  to  the  macrophages. 
Resident  and  proteose  peptone-elicited  macrophages  bound 
390 __. 130 and 420 +_ 160 KI.  brevis zymosan particles per 100 
macrophages, respectively, whereas thioglycollate-elicited mac- 
rophages bound 200 ---  150. Thus, consistent with the results 
described in Fig. 3,  thioglycollate-elicited macrophages bind 
fewer  zymosan particles  than  resident  or proteose  peptone- 
elicited macrophages. 
KI.  brevis  mannan is a much more potent inhibitor than S. 
cerevisiae  mannan of binding of KI.  brevis zymosan to macro- 
phages. The concentration causing 50% inhibition of KI. brevis 
zymosan  binding  to  proteose  peptone-elicited  macrophages 
was ~100/tg/ml for S.  cerevisiae mannan and ~3-5/tg/ml for 
KI. brevis mannan. KI. brevis mannan completely inhibited the 
binding of KL  brevis  zymosan to resident,  thioglycollate-elic- 
ited, and proteose peptone-elicited macrophages at concentra- 
tions above 20/~g/ml (data not shown). 
Modulation of Mannan Receptors by Substrate 
Adherent Ligands 
The  results  presented  to  this  point  confirm  that  specific 
mannan-inhibitable receptors mediate the binding of zymosan 
particles  to the  macrophage surface;  they suggest  that  these 
receptors mediate the internalization  of zymosan particles as 
well.  To examine these issues further we have examined the 
effects of ligand-coated surfaces on zymosan uptake,  a  tech- 
nique  that  has proved useful in analyzing the physiology of 
macrophage  Fc  and  complement  receptors  (19)  and  of the 
chicken  hepatocyte  galactose-binding  receptor  (33).  Macro- 
phages were plated  on coverslips coated with  PLL to which 
mannan  was  cross-linked;  the  macrophages were  then  incu- 
bated at 37°C with zymosan particles. Few of the macrophages 
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FIGURE  4  Effects of KI. brevis  mannan on ingestion of S. cerevisiae 
zymosan or IgG-coated erythrocytes by resident macrophages. Ex- 
perimental  protocol  is the same as in  Fig.  2. The amount of  IgG- 
coated  erythrocytes added  was  20 #1  of  2%  particles.  Uningested 
IgG-coated erythrocytes bound on the macrophages were lysed by 
hypotonic lysis in water. The total number of particles ingested by 
macrophages in control medium was approximately 400 and 600 per 
100 macrophages for zymosan and IgG-coated erythrocytes, respec- 
tively. O, zymosan ingestion; O, IgG-coated erythrocyte ingestion. 
plated on these mannan-coated coverslips for 2 h  before the 
addition of zymosan ingested any of these particles (Table II). 
Macrophages incubated on PLL-mannan for 24 h  before the 
addition of zymosan gave qualitatively similar results (Table 
II). In contrast, the capacity of macrophages plated on PLL- 
mannan to bind complement-coated erythrocytes and to ingest 
IgG-coated  erythrocytes  was  unimpaired  (Table  II).  These 
results confirm that the receptors that mediate zymosan binding 
and ingestion can be modulated by substrate adherent ligands 
without altering the activities of other classes of macrophage 
membrane receptors (i.e. Fc and complement receptors); more- 
over, in conjunction with  the  data  in  Fig. 4  they show that 
these receptor systems operate independently of one another. 
Chloroquine Inhibits Zymosan Phagocytosis 
Chloroquine  elevates  macrophage  intralysosomal  pH  (20) 
and promotes "down regulation" ofmacrophage Man/GlcNAc 
receptors  (29),  presumably by trapping  the  receptors  within 
intracellular  compartments  (12,  29).  As  shown  in  Fig.  5a, 
chloroquine inhibits zymosan phagocytosis in a dose-depend- 
ent manner, reaching 75% inhibition at 250/zM. Preincubation 
of macrophages in chloroquine enhances its  inhibitory effect. 
The inhibitory effect of chloroquine was further increased by 
including mannan in the preincubation medium. Under these 
last conditions,  10/.tM  chloroquine was sufficient to produce 
50% inhibition of zymosan phagocytosis. 
Macrophages  incubated  at  4°C  with  250 /~M  chloroquine 
bind  as  many  KL  brevis  zymosan  as  control  macrophages, 
indicating  that  the drug does not interfere  directly with  the 
interaction  of zymosan with  macrophage  receptors.  As  ex- 
pected,  macrophages preincubated  at  37°C  for  1 h  with  100 
/~M chloroquine exhibited  a  95% reduction in binding of KI. 
brevis zymosan (data not shown). 
In  all  cases,  the  inhibitory  effects  of chloroquine,  or  of 
chloroquine  plus  mannan,  on  zymosan  binding  (data  not 
shown)  and  phagocytosis (Fig.  5 b)  were  reversible.  Chloro- 
quine had no effect on the activity of other macrophage surface 
receptors examined.  For instance, treatment of resident mac- 
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Phagocytosis  of Resident  Macrophages  Plated  on PLL-Mannan 
Average 
no. of 
macro-  particles  Control 
phages  ingested  Phago-  phago- 
phago-  per mac-  cytic in-  cytic in- 
cytosing  rophage  dex  dex 
%  % 
Zymosan ingestion by macrophages prated for 2 h* on: 
PLL  93  3.5  320  100 
PLL-BSA  84  3.0  250  78 
PLL-mannan  13  1.8  23  7 
Zymosan ingestion by macrophages plated for 24 h~ on: 
PLL  85  6.1  522  100 
PLL-BSA  86  4.4  382  73 
PLL-mannan  41  2.5  102  19 
IgG-Coated erythrocyte ingestion by macrophages plated for 24 h§ 
on: 
PLL 
PLL-BSA 
PLL-mannan 
99  12.2  1,210  100 
93  9.4  874  72 
96  11.8  1,130  93 
Average 
no. of 
particles 
macro-  bound  Control 
phage  per mac-  Binding  binding 
binding  rophage  index  index 
%  % 
Complement-coated erythrocyte binding¶  by macrophages plated 
for 24 h on: 
PLL  100  18.3  1,830  100 
PLL-mannan  100  15.7  1,570  86 
* 8 X  104 resident macrophages were incubated on 13-mm coverslips coated 
with  the indicated  ligands at 37 °  in  MEM-10%  FBS for 2 h.  After washing 
three times with  MEM, these coverslips were placed  in 0.5  ml of MEM-2% 
FBS-25 mM  HEPES, 7.4  in  16-ram  costar  wells.  20 p.I  of  2%  5.  cerevisiae 
zymosan in PD were added and phagocytosis was allowed to proceed for 30 
rain at 37  '~. Only cells with well-spread membrane and macrophage  mor- 
phology were counted. 
:[: Macrophages were plated on  PLL, PLL-BSA and  PLL-mannan  coverslips as 
described  above. After incubation  at 37  °  for 24  h,  phagocytosis was per- 
formed as indicated. The results represent the average of four experiments. 
§ Macrophages on the indicated  coverslips were prepared  the same way as 
those used  in ~: above. For each coverslip in a 16-mm costar well containing 
0.5  ml  of  MEM-2%  FBS-25 mM  HEPES, pH  7.4, 20 /d  of  2%  IgG-coated 
erythrocytes were added.  After  phagocytosis  for 30  min,  coverslips were 
dipped  in water, washed with PD, fixed in glutaraldehyde, and counted as 
described in Fig. 4. 
¶ Macrophages  prepared  as  in  ~:  above  were  incubated  with  20 /d  of  2% 
complement-coated erythrocytes for 30 min at 37°C,  washed with PD, fixed 
in glutaraldehyde, and counted as described in  Fig. 4. 
rophages with chloroquine or with chloroquine plus mannan 
did not alter binding or ingestion of IgG-coated erythrocytes 
(data not shown), confirming again (cf. Fig. 4) that the receptor 
that mediates zymosan uptake functions independently of other 
macrophage receptor systems. 
Zymosan Uptake is Abolished by Trypsin and 
Reduced by Calcium Chelation 
The capacity of rat alveolar macrophages to bind mannose- 
BSA and  Candida  krusei is inhibited by trypsin treatment of 
the macrophages or by chelation of Ca ++ in the medium (26, 
32).  Incubation of resident macrophages with trypsin reduced 
the  capacity of these  ceils to  bind  and  ingest  S.  cerevisiae 
zymosan by 93% and 72% (mean of three experiments), respec- 
tively (data not shown). Incubation of macrophages in calcium- 
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FIGURE  5  (a)  Dose response of chloroquine inhibition of phago- 
cytosis of 5. cerevisiae  zymosan by mouse peritoneal macrophages. 
Washed  24-h  cultures  of  macrophages on  13-mm coverslips  (2  X 
10  s peritoneal cells/coverslip)  in  16-mm  Costar wells were prein- 
cubated at 37°C for 1 h with  500 #l of medium containing various 
concentrations  of  chloroquine  in  control  medium  (MEM-25  mM 
HEPES, pH 7.4-2%  FBS) with  (A) or without (@) 10 mg/ml mannan. 
The coversiips were then washed three times with cold MEM, and 
the medium was replaced with 500#i of control medium containing 
chloroquine without mannan and 0.08%  (vol/vol)  5. cerevisiae  zy- 
mosan.  Phagocytosis  was  performed  for  30  rain  at  37°C.  Macro- 
phages in O  were not preincubated with chloroquine or mannan, 
and  phagocytosis was  performed  in  chloroquine-containing  me- 
dium.  Phagocytosis  is  expressed  as  %  of  the  control  phagocytic 
index, which is 390 for these experiments. The results are the average 
of four experiments. (b)  Phagocytosis reversal of chloroquine inhi- 
bition.  Macrophages preincubated  for  1  h  in  50 #M  chloroquine 
(A),  10 mg/ml  mannan  ([~),  or 50 p.M chloroquine plus 10 mg/ml 
mannan (A) were washed three times with cold MEM and placed in 
warm control  medium. Zymosan particles were added at 0, 30, 60, 
90, and  120 min after preincubation  and phagocytosis was carried 
out for 30 min. The reversal time denotes the total amount of time 
after preincubation, and the phagocytic index for control is 420. The 
results are the_average of two experiments. 
free medium had no inhibitory effect on zymosan binding or 
phagocytosis. In contrast, addition of EGTA to the medium 
caused a  52-61% decrease in zymosan binding and a 43-45% 
decrease in zymosan ingestion by macrophages. The inhibitory 
effects of EGTA were overcome when excess Ca ++ was added 
to the medium. 
The  Man/GlcNAc  receptor  described  by  Townsend  and 
Stahl (30) requires Ca  ++ for ligand binding. Thus the failure of 
EGTA  to  completely block zymosan  binding  and  ingestion 
might result from participation of another receptor system in 
this process.  The  mannose  phosphate  receptor described by 
Kaplan et al. (15) has no Ca ++ requirement for ligand binding. 
To determine whether this receptor has any role in zymosan 
uptake, we incubated resident macrophages with EGTA and 
1 mg/ml phosphomannan monoester from Hansenula holstii or 
25  mM mannose-6-phosphate. Addition of these phosphoryl- 
ated saccharides did not enhance the inhibitory effect of EGTA 
(data not shown). 
Macrophage Receptors that Mediate Zymosan 
Uptake Recognize Neutral and Not 
Phosphorylated Mannans 
To search further for a possible role for a mannose phosphate 
receptor in zymosan uptake we compared the effects of man- 
nose-6-phosphate  and  mannose  phosphate-containing oligo- 
saccharides with  mannose,  mannose-containing oligosaccha- rides, dephosphorylated mannan,  and  a  mannose-containing 
glycoprotein on  zymosan binding and  phagocytosis. 50  mM 
mannose-6-phosphate was slightly less inhibitory than equal 
concentrations of mannose or mannobiose (Table III). None 
of these  saccharides  was  an  effective  inhibitor of zymosan 
binding or ingestion. Mannotriose and mannotetraose, derived 
from the acetolysis of S. cerevisiae mannan, were good inhibi- 
tors  at  50  mM  (Table  III) but  were  roughly comparable to 
mannose in inhibitory potency when their concentrations were 
corrected for their mannose content (e.g. l0 mM mannotetraose 
equals 40 mM mannose). D-Glucose, L-fucose and o-galactose 
at 50 mM had no effect on either the binding or phagocytosis 
of zymosan by macrophages (data not shown). 
To  examine the effect of mannan  phosphorylation on  zy- 
mosan  uptake  we  used  mild  acid  hydrolysis  and  alkaline 
phosphatase to degrade KL brevis mannan (mannose:phosphate 
ratio = 8.6: l) in a stepwise fashion. Mild acid treatment resulted 
in only a small reduction in the inhibitory potency of Kl. brevis 
mannan (Fig. 6). Alkaline phosphatase treatment of this acid- 
hydrolyzed mannan removed 65% of the phosphate groups but 
caused  no  further  change  in  the  inhibitory potency  of the, 
mannan (Fig. 6). 
In a related series of experiments, exocellular mannans with 
high phosphate content  that  had  been hydrolysed with mild 
acid to expose their mannose-6-phosphate groups were tested 
for their ability to inhibit the phagocytosis of zymosan particles 
by  macrophages.  They  were  no  more  inhibitory  than  the 
corresponding neutral mannans (Table I). O-Phosphonoman- 
nan  monoesters, such as one from Hansenula holstii  that po- 
tently inhibits fl-glucuronidase uptake by the fibroblast man- 
TABLE  III 
Effects of Glycoproteins and Sugars  on  the Phagocytosis And 
Binding of Zymosan by Macrophages * 
Phagocyto-  Binding 
Concentra-  sis (% con-  (% con- 
Inhibitor  tion  trol)  trol) 
Horseradish peroxidase  30 mg/ml  13 +- 8  1 +  0.7 
10 mg/ml  28 +  2  7 +  6 
D-Mannose  50 mM  57 _  24  65 _+ 29 
Mannobiose~  50 mM  ND§  50¶ 
Mannotriose  50 mM  ND  11¶ 
25 mM  ND  53 +  16 
10 mM  ND  121¶ 
Mannotetraose  50 mM  ND  7¶ 
25 mM  ND  22 +  6 
10mM  ND  69+8 
a-MethyI-D-mannopyran-  50 mM  101 +_ 8  89 +  25 
oside 
Mannose-6-phosphate  50 mM  68 +  16  80 +_ 23 
* Macrophages  (8 x  10" macrophages per 13-mm coverslip)  in MEM-10%  FBS 
were  incubated  overnight  at  37°C,  washed,  pretreated  with  the  listed 
compounds  in 0.5 ml of MEM-2%  FBS-25 mM  HEPES, pH  7.4 for 15  min at 
37~C for phagocytosis  and 4°C for binding  before the addition of particles. 
For binding, 20/~1 of 5%  KL brevis zymosan was added to proteose peptone- 
elicited  macrophages and  the cultures were allowed  to stand  at 4°C for 90 
min.  For  phagocytosis,  20  #1  of  2%  5.  cerevisiae  was  added  to  resident 
macrophages  and  the  cultures  were  incubated  at  37°C  for  30  min.  The 
number of  particles  ingested  or  bound  was scored  by  phase-contrast  mi- 
croscopy. 50-mM sugar solutions were adjusted to a final osmotarity of 300 
mosmote  by dissolving  the sugars  in  a solution  of 3 parts  MEM-2%  FBS-25 
mM HEPES pH 7.4 and 1 part distilled water. The results represent the mean 
of two to three experiments and are expressed as mean -+ standard deviation. 
:1: Acetolysis products of 5. cerevisiae mannan were preincubated with resident 
macrophages (24 h in culture) for 15 rain. at 4°C before additior~ of KL brevis 
zymosan. 
§ Not done. 
¶ Experiments were performed once. 
40C 
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FIGURE  6  Phagocytosisinhibition by KI. 
brevis  mannan  treated  with  mild  acid 
and  alkaline phosphatase. 20 mg of  KL 
brevis mannan were treated with 0.01 M 
HCI at 100 °  for 30 min. After dialysis, an 
aliquot of the acid-treated mannan in 0.8 
ml of 0.75 M  Tris HCI pH 8.0 was treated 
with 49 U of alkaline phosphatase for 24 
h.  Phagocytosis  inhibition  was  per- 
formed as in Fig. 2. •  KI. brevis mannan; 
0.o~  oi  O  acid  hydrolysed;  @,  acid  hydrolysed 
[MANNAN](mg/ml)  and  alkaline  phosphatase-treated  KI. 
brevis mannan. The mannan used was from a slightly less inhibitory 
batch. 
nose-6-phosphate receptor (50% inhibition =  0.2 #g/ml [refer- 
ence  10]), were  also ineffective. On  a  weight  basis, the  best 
inhibitors of phagocytosis among several exocellular mannans 
tested  were  the  O-phosphonoglucomannan  and  the  neutral 
glucomannan from Pichia pinus.  Pichia pinus mannan contains 
almost exclusively glucose as the nonreducing end group (24). 
A glucogalactan from Sporobolomyces sp. (23) that has predom- 
inantly glucose at the nonreducing terminal and contains no 
mannose also inhibited phagocytosis to an appreciable extent 
(Table I). Thus glucose appears to compete for the binding site 
for zymosan particles. 
Horseradish peroxidase is reported to contain no phospho- 
rylated oligosaccharides (34), and we have confirmed that the 
peroxidase used  in our experiments has  no  detectable phos- 
phate. It is a very effective inhibitor of zymosan binding and 
phagocytosis (Table III). Moreover, in experiments to be re- 
ported elsewhere, we have found that pinocytosis of HRP by 
mouse macrophages can be inhibited to a significant degree by 
mannan. Thus mannan and HRP bind to the receptors exhibit- 
ing similar ligand specificity. 
In summary, the results reported here show  that zymosan 
binding  and  phagocytosis can  be  inhibited  by  micromolar 
concentrations of KI. brevis mannan and by somewhat higher 
concentrations of other mannose-containing oligosaccharides 
and glycoproteins; that phosphorylated mannose  residues do 
not contribute to the inhibitory effects of the saccbarides or 
glycoproteins used in these experiments; that the macrophage 
surface structures that mediate zymosan uptake can be modu- 
lated  by  substrates  coated  with  mannan;  that  they  can  be 
"down regulated" by mannan in the presence of chloroquine, 
destroyed by trypsin, and inhibited by Ca ++ chelation. These 
treatments have no effect on  the binding or phagocytosis of 
IgG-coated erythrocytes by macrophage  Fc receptors. These 
findings indicate that zymosan binding and phagocytosis are 
mediated by a specific membrane receptor and that the receptor 
is similar in its ligand-binding requirements, trypsin sensitivity, 
and  requirement for Ca  ++  to the Man/GlcNAc receptor de- 
scribed by Stahl and his colleagues (25, 26). We conclude that 
zymosan uptake is mediated by this Man/GlcNAc receptor. 
Thus  the  mannose  receptor,  like  the  Fc  and  complement 
receptors  (27,  31),  mediates  both  adsorptive  pinocytosis  of 
soluble molecules and phagocytosis of particulate materials. 
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